Mechanisms of tamoxifen-induced apoptosis
1Department of Drug Metabolism and Pharmacokinetics, DuPont Pharmaceuticals Company, Newark, DE 19711, USA. sandhya.mandlekar@dupontpharma.com
Abstract:
Tamoxifen (TAM) has been used in the treatment of breast cancer for over a decade. The observed clinical efficacy of TAM has been attributed to both growth arrest and induction of apoptosis within the breast cancer cells. Although the primary mechanism of action of TAM is believed to be through the inhibition of estrogen receptor (ER), research over the years has indicated that additional, non-ER-mediated mechanisms exist. These include modulation of signaling proteins such as protein kinase C (PKC), calmodulin, transforming growth factor-beta (TGFbeta), and the protooncogene c-myc. Recent studies, including those from our laboratory, have implicated the role of caspases and mitogen-activated protein kinases (MAPK), including c-Jun N-terminal kinase (JNK) and p38 in TAM-induced apoptotic signaling. Oxidative stress, mitochondrial permeability transition (MPT), ceramide generation as well as changes in cell membrane fluidity may also play important roles in TAM-induced apoptosis. These various signaling pathways underlying TAM-induced apoptosis will be reviewed in this article.
Insights
Tamoxifen (TAM) effectively treats breast cancer by inducing apoptosis. Beyond estrogen receptor (ER) inhibition, TAM utilizes non-ER pathways involving caspases, MAPKs, and oxidative stress for its anti-cancer effects.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Tamoxifen (TAM) is a widely used breast cancer therapeutic.
- Its efficacy is linked to growth arrest and apoptosis induction in cancer cells.
- While primarily acting via estrogen receptor (ER) inhibition, non-ER mechanisms are increasingly recognized.
Purpose of the Study:
- To review the diverse signaling pathways involved in Tamoxifen-induced apoptosis.
- To highlight both ER-dependent and ER-independent mechanisms of TAM action.
- To consolidate current understanding of TAM's molecular effects on breast cancer cells.
Main Methods:
- Literature review of studies on Tamoxifen's mechanism of action.
- Analysis of research investigating signaling proteins modulated by TAM.
- Examination of studies exploring oxidative stress and mitochondrial pathways in TAM response.
Main Results:
- TAM induces apoptosis through ER-dependent and independent pathways.
- Key signaling proteins modulated by TAM include PKC, TGFbeta, c-myc, caspases, and MAPKs (JNK, p38).
- Oxidative stress, MPT, ceramide, and cell membrane fluidity changes contribute to TAM-induced apoptosis.
Conclusions:
- Tamoxifen's anti-cancer effects are multifaceted, involving complex intracellular signaling networks.
- Understanding these diverse pathways is crucial for optimizing breast cancer treatment strategies.
- Further research into non-ER-mediated mechanisms may reveal novel therapeutic targets.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy


